Kodiak Net Margin

The Net Margin of Kodiak Sciences Inc (KOD) is N/A.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

Kodiak Net Margin - Peers Comparison

Ticker	Name	Value
ARNA	Arena Pharmaceuticals Inc	-1141542.60%
MRTX	Mirati Therapeutics Inc	-5955.55%
VRTX	Vertex Pharmaceuticals Inc	-4.86%
ABBV	Abbvie Inc	7.59%
ALLO	Allogene Therapeutics Inc	-1170863.70%
CCXI	ChemoCentryx Inc	-408.87%
CRSP	CRISPR Therapeutics AG	-981.54%
LEGN	Legend Biotech Corp	-28.22%
MRNA	Moderna Inc	-110.04%
APLS	Apellis Pharmaceuticals Inc	-25.32%
ASND	Ascendis Pharma A/S	-103.97%
FATE	Fate Therapeutics Inc	-1366.46%
FGEN	FibroGen Inc	-160.63%
SWTX	SpringWorks Therapeutics Inc	-134.73%
XLRN	Acceleron Pharma Inc	-179.45%
950200.KQ	Psomagen Inc	-13.29%
BHVN	Biohaven Ltd	-1205.09%
GILD	Gilead Sciences Inc	1.67%
IONS	Ionis Pharmaceuticals Inc	-64.38%
RVMD	Revolution Medicines Inc	-3768.28%
BPMC	Blueprint Medicines Corp	-13.19%
HALO	Halozyme Therapeutics Inc	43.74%
VIE	Viela Bio Inc	-1293.07%
ALXO	ALX Oncology Holdings Inc	-3876.27%
IOVA	Iovance Biotherapeutics Inc	-226.84%
REGN	Regeneron Pharmaceuticals Inc	31.07%
RLAY	Relay Therapeutics Inc	-3374.72%
SRPT	Sarepta Therapeutics Inc	12.37%
TGTX	TG Therapeutics Inc	7.11%
TPTX	Turning Point Therapeutics Inc	-767.30%
950160.KQ	Kolon TissueGene Inc	-666.19%
AMGN	Amgen Inc	12.24%
IGMS	IGM Biosciences Inc	-7308.51%
NTLA	Intellia Therapeutics Inc	-896.77%